Jade Biosciences (JBIO) Change in Account Payables (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Change in Account Payables data on file, last reported at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 13.04% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $12000.0 (down 99.77% YoY), and the FY2025 full-year result was $361000.0, up 116.62% from the prior year.
• Change in Account Payables for Q1 2026 stood at $2.3 million, up from $301000.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $2.7 million in Q1 2025 and bottomed at -$4.9 million in Q3 2025.
• The 5-year median for Change in Account Payables is $835000.0 (2024), against an average of $427294.1.
• The widest annual swing landed in 2024, when Change in Account Payables soared 223.56%; it then tumbled 1736.91% in 2025.
• A 5-year view of Change in Account Payables shows it stood at -$1.7 million in 2022, then jumped by 40.31% to -$1.0 million in 2023, then jumped by 223.56% to $1.3 million in 2024, then tumbled by 76.67% to $301000.0 in 2025, then surged by 673.42% to $2.3 million in 2026.
• The last three Change in Account Payables figures came in at $2.3 million (Q1 2026), $301000.0 (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison